07:00 , Jul 15, 2013 |  BC Week In Review  |  Company News

AriBio, SK Biopharmaceuticals deal

The companies partnered to conduct preclinical and clinical development of SK Biopharmaceuticals' SKL-G to treat glaucoma. The companies have been testing the small molecule, which has an undisclosed mechanism of action, in animal models since...